Atlas Trials

Chromosomal Instability as a Surrogate Biomarker of Drug Resistance in Immunotherapy for Lung Cancer Patients

Clinical trial NCT04203095 · UNKNOWN

Trial details

NCT number
NCT04203095
Sponsor
Shanghai Pulmonary Hospital, Shanghai, China
Status
UNKNOWN
Study type
OBSERVATIONAL
Lung Cancer
Start date
2019-11-10
Primary completion
2020-11-11
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.